Vutrisiran

1 Drug classified under this active ingredient

siRNA. Vutrisiran 25 mg/0.5 ml.
Pre-filled syr. sol for inj. 1 X 0.5 ml
25 mg once every 3 months as SC inject.
For hereditary transthyretin amyloidosis in adults with stage 1 or stage 2 polyneuropathy (hATTR-PN). For wild-type or hered. transthyretin amyloidosis in adults with cardiomyopathy (ATTR-CM).
C/I: Hypersens.